Newsdesk
Follow Medasense’s accomplishments and news
Medasense to Provide Pain Index Solution for Treatment of Dementia Patients
December 19, 2019
Medasense has been awarded a development grant to extend the application of its NOL pain response monitoring index for noncommunicating dementia patients.
Medasense selected as one of 50 top companies
July 2, 2019
MedTech Innovator selected Medasense for its innovation and accomplishments, as one of 50 top companies to present at the 2019 Showcase in San Francisco.
Medasense Announces Compatibility with Philips IntelliVue Patient Monitors
January 9, 2019
Medasense’s NOL technology for nociception monitoring is now compatible with Philips IntelliVue patient monitors.
NOL technology latest clinical outcomes
October 29, 2018
Medasense announces positive results from clinical outcome studies, evaluating the role of the NOL technology in guiding opioid administration during surgery for improved outcomes.
PMD-200™ and the NOL index are commercially available in Australia!
October 1, 2018
We are happy to share with you that Medasense received approval to market the PMD-200™ system in Australia.